Rising Risks: Why Hepatitis B Vaccination Rates Among Newborns Are Declining

Public health officials are raising alarms as the United States faces a potential resurgence of hepatitis B in infants. Recent data reveals a troubling downward trend in vaccination rates, compounded by significant shifts in federal health guidance. For newborns, the stakes are incredibly high: a lack of timely vaccination can lead to lifelong chronic illness and deadly complications.

The Current Trend: A Decline in Newborn Vaccinations

Vaccination rates for hepatitis B among newborns have seen a significant drop. A recent study utilizing national electronic health record data found that these rates declined by more than 10% between 2023 and August 2025, according to a report by the Los Angeles Times.

This decline doesn’t happen in a vacuum. The U.S. Is already seeing a comeback of other preventable diseases. Measles, for example, has seen more than 1,500 reported cases in the first few months of 2026. This puts the country on track to surpass last year’s total of over 2,200 cases, the highest number seen in decades.

Why the Birth Dose is Critical

To the average parent, hepatitis B might seem like an unlikely threat to a newborn. But, the virus spreads through infected blood or bodily fluids and infants are more vulnerable than they appear.

How Infants Are Exposed

Before routine vaccination was established, roughly 18,000 children under age 10 were infected with hepatitis B every year in the U.S. These infections typically occurred in two ways:

• Mother-to-Child Transmission: About half of all infections were passed from the mother to the child during birth.
• Household Exposure: The remaining infections occurred through everyday contact with caregivers or family members who were unaware they were infected.

The Long-Term Consequences

The danger for infants is far greater than for adults. While an acute infection might be mild or asymptomatic, as many as 90% of babies infected in their first year of life develop chronic hepatitis B. Over time, this chronic infection can lead to severe health crises, including liver failure, cirrhosis, and liver cancer.

Federal Policy Shifts and Controversy

The decline in vaccination rates coincides with a major shift in federal guidance. On December 5, the Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel voted to remove the decades-old recommendation for the birth-dose vaccine.

This change was pushed by Health and Human Services Secretary Robert F. Kennedy Jr. And the “Develop America Healthy Again” movement, which aims to rewrite the CDC’s childhood vaccine schedule and unwind state immunization requirements for kindergarten, as reported by Yahoo News.

State-Level Resistance

Not all health officials agree with the federal rollback. California, Hawaii, Oregon, and Washington have formed the West Coast Health Alliance to maintain uniform public policy on vaccines. California officials have vowed to preserve their current guidelines in place, fearing that federal changes could threaten vaccine coverage by public benefits programs and some insurers.

Key Takeaways for Parents and Caregivers

• High Risk for Infants: Up to 90% of babies infected with hepatitis B in their first year develop a chronic infection.
• Declining Rates: Newborn vaccination rates dropped by over 10% between 2023 and August 2025.
• Policy Changes: The CDC’s advisory panel has voted to nix the birth-dose recommendation, though some states are fighting to keep it.
• Severe Outcomes: Chronic hepatitis B is a leading cause of liver cancer and liver failure.

Frequently Asked Questions

Why is the birth dose given so early?

The birth dose is the primary defense against mother-to-child transmission during delivery and protects infants from household exposure during their most vulnerable window of development.

Does the CDC still recommend the vaccine?

The CDC’s vaccine advisory panel voted on December 5 to remove the birth-dose recommendation for all newborns, though this move has been met with objections from various health officials.

Are all states following the modern federal guidance?

No. States including California, Hawaii, Oregon, and Washington have formed an alliance to maintain their existing vaccine guidelines despite the federal shift.

Looking Ahead

As federal and state guidelines diverge, the risk of “vaccine confusion” increases. With childhood vaccination rates declining and preventable diseases like measles returning, the potential for a hepatitis B resurgence poses a significant threat to pediatric liver health across the United States.